-
Rybakina tops Osaka, sets US Open quarter-final clash with Zheng
-
Osaka seeks answers to nagging achilles injury after US Open exit
-
Panama Canal considering more cuts in transits due to El Nino
-
Flight data recorders recovered from Amazon cargo plane crash
-
Maresca agrees with Haaland that players started season jaded
-
Super Bowl rematch kicks off NFL season as league expands global reach
-
Hurricane warning issued for westernmost Hawaiian islands
-
Alcaraz faces Shelton in blockbuster US Open quarter-final
-
UK PM denounces 'politics of poison' after anti-migrant protests
-
Trump threatens sales in US of Canadian aircraft maker Bombardier
-
Comeback queen Zheng strikes again for US Open quarter-final berth
-
Eiffel Tower closed in row over women removed for Hindu group
-
Third absence for injured Hadjar as Lawson fills in again in Spain
-
Willemse replaces Kolbe for Springboks' All Blacks series decider
-
Far-right victory in Germany draws protesters in Berlin
-
Zheng shocks Swiatek in another incredible US Open comeback
-
CapTLX Launches Institutional Gateway to U.S. Private Markets, Expanding Access to Structured Investment Opportunities
-
Andreeva survives in three sets against Potapova
-
Africa's richest man eyes continent's largest IPO
-
Alleged killers of Australian, US surfers go on trial in Mexico
-
Macron, SKorea leader warn at film summit of AI risks to creativity
-
King Charles classes Harry and Meghan as 'private citizens'
-
'Impressive' Alcaraz has Shelton in sights in US Open quarter-final
-
Bowling coach Noffke says Pakistan's off-field issues are nothing new
-
Noosha Aubel a krize v Postupimi: Jak dlouho je ještě možné tolerovat toto selhání vedení?
-
Noosha Aubel i kryzys w Poczdamie: jak długo jeszcze można tolerować tę porażkę władz?
-
Η Noosha Aubel και η κρίση του Πότσνταμ: Για πόσο ακόμα είναι ανεκτή αυτή η διαχειριστική αποτυχία;
-
ヌーシャ・オーベルとポツダムの危機:この指導力の欠如は、いつまで容認され続けるのか?
-
Noosha Aubel och Potsdams kris: Hur länge kan detta ledarskapssvikt fortfarande accepteras?
-
Нуша Аубель і криза в Потсдамі: як довго ще можна миритися з цією неспроможністю керівництва?
-
Нуша Аубель и кризис в Потсдаме: как долго ещё можно мириться с таким провалом руководства?
-
نوشا أوبيل وأزمة بوتسدام: إلى متى سيظل هذا الفشل القيادي مقبولاً؟
-
努莎·奧貝爾與波茨坦的危機:這種領導失職還能容忍多久?
-
누샤 아우벨과 포츠담의 위기: 이러한 리더십 부재는 얼마나 더 용인될 수 있는가?
-
नूशा ऑबेल और पॉट्सडैम का संकट: नेतृत्व की इस विफलता को और कितना सहन किया जा सकता है?
-
Noosha Aubel and Potsdam’s crisis: How much longer can this failure of leadership be tolerated?
-
England quick Archer in 'good place' after injuries
-
US envoy sees 'movement' toward three-way talks with Russia, Ukraine
-
Robots protest rampant AI in Poland
-
Thousands bid farewell to Bosnian Serb war criminal in Belgrade
-
Rare woman director in Venice sees industry backsliding on gender
-
EU chief announces 200-mn-euro investment package for Greenland
-
France, SKorea warn at film summit of AI risks to creativity
-
Lebanon says Israel conducts wave of deadly strikes
-
Z Traders Introduces New Funding Model Designed to Expand Opportunities in Trading
-
Cipheras Group - Apex AI Fund Deploys 290-Billion-Parameter Proprietary Large Language Model
-
Lebanon says 12 killed in strikes as Israel vows to 'remove threats'
-
Germany's Merz 'shocked' by far-right state win but vows to stay course
-
Volkswagen plant to be converted for Israeli defence group
-
UK finance minister Healey pledges strict fiscal discipline as budget looms
New Zealand approves medicinal use of 'magic mushrooms'
New Zealand on Wednesday approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called "magic mushrooms".
Deputy Prime Minister David Seymour said rules had been relaxed so psilocybin could be used to treat certain types of depression.
Psilocybin is a naturally occurring psychedelic compound found in some species of mushroom and can cause hallucinations and an altered state of mind.
"Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression," Seymour said.
"This is huge for people with depression who've tried everything else and are still suffering.
"If a doctor believes psilocybin can help, they should have the tools to try."
There will be tight rules for prescribing the drug.
Only psychiatrists who have been involved in psilocybin clinical trials will be allowed to prescribe it, and they must strictly report its use and keep detailed records.
Party drugs such as as MDMA and magic mushrooms are increasingly being used in mainstream medical settings, helping treat post-traumatic stress disorder and depression.
Australia approved the medicinal use of psilocybin in 2023.
F.AbuShamala--SF-PST